Celularity, Inc. (CELU)
0.7748
-0.03
(-3.16%)
USD |
NASDAQ |
Aug 24, 16:00
0.7719
0.00 (0.00%)
After-Hours: 20:00
Celularity Profit Margin (Quarterly) : -593.6% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -593.6% |
| September 30, 2025 | -436.7% |
| June 30, 2025 | -427.5% |
| March 31, 2025 | -172.9% |
| December 31, 2024 | -73.31% |
| September 30, 2024 | -173.2% |
| June 30, 2024 | -53.57% |
| March 31, 2024 | -149.9% |
| December 31, 2023 | 78.82% |
| September 30, 2023 | -2.48K% |
| June 30, 2023 | -1.63K% |
| Date | Value |
|---|---|
| March 31, 2023 | -1.63K% |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -1.06K% |
| December 31, 2021 | -83.16% |
| September 30, 2021 | |
| June 30, 2021 | -2.02K% |
| March 31, 2021 | -3.07K% |
| December 31, 2020 | |
| September 30, 2020 | -1.38K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -- |
| Exicure, Inc. | -- |
| Century Therapeutics, Inc. | -- |
| Absci Corp. | -10.44K% |
| Cardio Diagnostics Holdings, Inc. | -27.81K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -46.78% |
| Return on Invested Capital | -169.9% |
| Gross Profit Margin (Quarterly) | -123.6% |
| Operating Margin (Quarterly) | -537.5% |
| Return on Net Operating Assets | -86.11% |